Skip to main content
logo
Ascelia Pharma AB (publ) (STO:ACE)
Sweden flag Sweden · Delayed Price · Currency is SEK
2.885
-0.015 (-0.52%)
May 22, 2026, 5:29 PM CET

Ascelia Pharma AB Cash Flow Statement

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-70.9-76.25-80.03-109.29-131.22-125.9
Depreciation & Amortization
0.890.890.941.051.051.03
Stock-Based Compensation
3.424.164.342.931.635.92
Other Operating Activities
-0.340.998.380.35-11.38-11.08
Change in Accounts Receivable
1.213.4-4.991.62-1.36-0.9
Change in Accounts Payable
-1.51-2.693.21-14.359.722.26
Change in Other Net Operating Assets
-3.96-2.755.31-9.116.3112.11
Operating Cash Flow
-71.2-72.25-62.84-126.79-125.26-116.56
Capital Expenditures
-0.06-0.06----0.04
Other Investing Activities
---0.05-0.07-
Investing Cash Flow
-0.06-0.06-0.05-0.07-0.04
Short-Term Debt Issued
--32.73---
Long-Term Debt Issued
--0.73---
Total Debt Issued
--33.46---
Short-Term Debt Repaid
--20-7.5---
Long-Term Debt Repaid
--0.81-0.89-0.91-1.02-0.94
Total Debt Repaid
-20.79-20.81-8.39-0.91-1.02-0.94
Net Debt Issued (Repaid)
-20.79-20.8125.07-0.91-1.02-0.94
Issuance of Common Stock
72.8372.83105.32-0.3200.4
Repurchase of Common Stock
-----0.3-0.4
Other Financing Activities
-3.81-3.81-15.21-0.03-0.08-14.19
Financing Cash Flow
48.2348.21115.19-0.94-1.1184.87
Foreign Exchange Rate Adjustments
-0.39-1.31.06-0.0214.388.64
Miscellaneous Cash Flow Adjustments
0---0--
Net Cash Flow
-23.41-25.453.4-127.7-112.0476.91
Free Cash Flow
-71.25-72.31-62.84-126.79-125.26-116.6
Free Cash Flow Per Share
-0.59-0.64-1.16-3.76-3.60-3.54
Cash Interest Paid
0.821.745.220.120.050.08
Cash Income Tax Paid
--0.07-1.45-1.17-3.77-1.02
Levered Free Cash Flow
-62.8-63.09-16.1-87-74.73-74.23
Unlevered Free Cash Flow
-62.8-62.03-13.78-87-74.7-74.18
Change in Working Capital
-4.27-2.043.53-21.8414.6713.47
Source: S&P Global Market Intelligence. Standard template. Financial Sources.